CD274 and neoplasm: Irrespective of subgroup classification (high or low PD‐L1, TMB, or neoantigen levels), patients in the tumor‐informed ctDNA+ group exhibited superior PFS and OS with ICI‐chemo compared to chemotherapy (log‐rank p < 0.05).